Health Care·Health Care Equipment·$13.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.88 | N/A | -25.71% |
management commentary, guidance changes, and full analysis available with Pro.
| -25.71% |
Tone: Defensive
Overall, management acknowledged the difficulties faced during the quarter. They emphasized a focus on adapting to market conditions.
Management expressed concerns about ongoing market challenges.
They highlighted the need for strategic adjustments moving forward.
Insulet Corp's disappointing EPS result indicates challenges in profitability, contributing to a 5.07% drop in stock price. Investors may be concerned about the company's ability to navigate current market conditions effectively. The lack of guidance adds uncertainty to future performance expectations.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
EXELON CORP
Oct 23, 2009